Abstract:The EGF signaling system plays a major role in the embryo-uterine dialogue during implantation and heparin-binding EGF-like growth factor (HBEGF) serves a role in coordinating embryonic and endometrial development at the site of blastocyst attachment. Implantation in mutant mice lacking HBEGF is delayed, but partially rescued by compensatory upregulation of amphiregulin. As implantation proceeds, HBEGF stimulates trophoblast differentiation and invasive activity essential for placentation. Therefore, we investigated the effects of embryonic HBEGF deficiency on placental development by breeding mice heterozygous for the HBEGF null mutation. Placentas and fetuses were removed on gestation day 14 and weighed. Fetuses were assayed to establish the genotype of corresponding placentas. Placental discs were halved, fixed and embedded in paraffin for sectioning. Central cross sections were deparaffinized for hematoxylin and eosin staining, immunohistochemistry or cell death (TUNEL) assay. Image analysis was used for semiquantification of immunohistochemical staining intensity. Weights of wild type (77.4 ± 3.5 mg; N=12) and heterozygous (76.5 ± 19.3 mg; N=32) placentas were similar, but homozygous null placentas had reduced average weights (59.8 ± 16.0 mg; N=21, p<0.01). Average fetal weight was not significantly affected by genotype. HBEGF immunostaining was gene dose-dependent and differed significantly among the three groups, with heterozygotes having an intermediate level. Other members of the EGF family, amphigreglin, TGF-alpha and EGF were expressed equally in wild type and homozygous null placentas. Histological examination revealed no apparent differences in trophoblast giant cells, but the spongiotrophoblast region was reduced compared to labyrinth in homozygous null placentas. Morphometric assessment of relative area demonstrated that spongiotrophoblast comprised a smaller (p<0.05) proportion of the cross sectional area in null placentas than in the wild type; however, heterozyotes were intermediate and did not differ significantly from the other two genotypes. There were no differences in apoptosis, but proliferation, assessed by nuclear Ki67 staining, was elevated (p<0.05) in the labyrinth and decreased (p<0.05) in the spongiotrophoblast of HBEGF null placentas compared to the wild type. Labyrinth morphology appeared disrupted in HBEGF null placentas stained with laminin to highlight capillary basement membrane. Indeed, the density of laminin-labeled capillaries was decreased (p<0.05) in HBEGF null placentas compared to the wild type, based on morphometric analysis. Immunohistochemical staining revealed reduced vascular endothelial growth factor (VEGF) in both spongiotrophoblast (p=0.06) and labyrinth (p<0.01) regions of HBEGF null placentas, suggesting that poor angiogenesis was due to reduced VEGF. These findings support an active role for HBEGF in placentation. Production of HBEGF by adjacent maternal tissues could have limited the detrimental effects of embryonic HBEGF deficiency. While there was no clear evidence of aberrant giant cell invasion in placentas lacking HBEGF, roles for HBEGF in spongiotrophoblast formation and fetal angiogenesis within the labyrinth were supported. HBEGF could promote fetal capillary formation by inducing VEGF or other angiogenic factors in the developing placenta. Supported by NIH grant HD12304 and the intramural research program of NICHD.

Placentation defects are highly prevalent in embryonic lethal mouse mutants

Implantation and Gastrulation Abnormalities Characterize Early Embryonic Lethal Mouse Lines

Defects in placental syncytiotrophoblast cells are a common cause of developmental heart disease

Deletion of Pdcd5 in mice led to the deficiency of placenta development and embryonic lethality

Genome-Wide Gene Expression Profiling Reveals Aberrant Mapk and Wnt Signaling Pathways Associated with Early Parthenogenesis

Embryonic Lethal Phenotyping to Identify Candidate Genes Related with Birth Defects

Analysis of Placental Arteriovenous Formation Reveals New Insights into Embryos with Congenital Heart Defects

Early Embryonic Lethality in Genetically Engineered Mice: Diagnosis and Phenotypic Analysis

Developmental Genes During Placentation: Insights from Mouse Mutants

Use of transgenic mice model for understanding the placentation: towards clinical applications in human obstetrical pathologies?

Dynamic Proteomic Profiles of in Vivo- and in Vitro-Produced Mouse Postimplantation Extraembryonic Tissues and Placentas

Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice

Deficiency of Antisense Lncrna Gm48853 Resulted in Embryonic Lethality and Impaired Placental Development in Mice

Maternal HBEGF Deficiency Restricts Placentation in Mice.

Disruption of the Endothelial Cell Protein C Receptor Gene in Mice Causes Placental Thrombosis and Early Embryonic Lethality*

Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse

Junb is Essential for Mammalian Placentation

Uterine injury during diestrus leads to placental and embryonic defects in future pregnancies in mice

Placental development and function in trisomy 21 and mouse models of Down syndrome: Clues for studying mechanisms underlying atypical development

Transcriptional Regulator BPTF/FAC1 Is Essential for Trophoblast Differentiation during Early Mouse Development

Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene